Remove Controlled Substances Remove Events Remove FDA
article thumbnail

Compass plans $100m IPO to fund magic mushroom depression drug

pharmaphorum

The FDA approved Spravato last year but after a troubled clinical development with mixed results from clinical trials and question marks over side effects, with increased risks for dissociation, abuse and suicidality observed. The post Compass plans $100m IPO to fund magic mushroom depression drug appeared first on.

article thumbnail

Contrave alternatives: What can I take instead?

The Checkup by Singlecare

Food and Drug Administration (FDA) for weight management in adults who are overweight or obese. Contrave has an FDA-mandated black box warning due to the risk of suicidal thoughts and behaviors associated with bupropion, the antidepressant ingredient. Tenuate is classified as a Schedule IV controlled substance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ACI’s 42nd FDA Boot Camp – New York City Edition

The FDA Law Blog

The American Conference Institute’s (“ACI’s”) popular “FDA Boot Camp”—now in its 42nd iteration—is scheduled to take place from March 13-14, 2024, at the SpringHill Suites NY Manhattan Times Square South, New York. Join the “Who’s Who” of the FDA Bar and don’t miss your opportunity to join their ranks! Join our co-chairs Kurt R.

FDA 59
article thumbnail

HP&M’s Larry Houck A Panelist at FDLI’s Cannabis Regulation Conference

The FDA Law Blog

Last August the Food and Drug Administration (“FDA”)/Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. April 4th and 5th, is an in-person and virtual event.

article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

It is a Drug Enforcement Administration (DEA) controlled substance in the Schedule II category. Non-amphetamine-based ADHD treatments, such as Strattera , are not controlled substances. Food and Drug Administration (FDA) in 2007 for treatment and symptom control in ADHD.

Dosage 92
article thumbnail

Can you take Vyvanse for weight loss?

The Checkup by Singlecare

That’s why you may have seen people talk about a medication called Vyvanse, which is FDA approved to treat ADHD and binge eating disorder, as a good option for weight loss. In 2015, the FDA approved Vyvanse to be used in the treatment of binge eating disorder. Does Vyvanse cause weight loss?

Labelling 125
article thumbnail

Gabapentin side effects in men

The Checkup by Singlecare

In fact, its kind of a jack-of-all-trades drug, approved by the Food and Drug Administration (FDA) to treat epilepsy, postherpetic neuralgia, and restless leg syndrome. Its not federally classified as a controlled substance by the Drug Enforcement Administration, but some states consider it to be one.